MYCENAX BIOTECH INC. financial statements, including revenue, expenses, profit, and loss
The total revenue of 4726 for the last quarter is 182.92 M TWD, and it's 61.50% higher compared to the previous quarter. The net income of Q4 23 is -152.50 M TWD.